Further, combinatorial treatment of MAb and Doxorubucin of HCT-116 xenografts resulted in significant regression of the pre-formed tumor validating the effectiveness for Notch1 MAb in adjuvant chemotherapy. This evidence concerns the gene NOTCH1 and neoplasm.